Scientific Leadership

The MRF’s Scientific Leadership is comprised of multidisciplinary experts in basic and translational research, dermatology, epidemiology, genomics, pathology, surgery and medical oncology. Membership includes representatives from the private and public sector.

Members of the MRF’s Scientific Advisory Committee (SAC) are listed below. Learn more about the CURE OM Scientific Steering Committee and the Pediatric Steering Committee and the MRF Breakthrough Consortium.

Co-Chairs:

Michael B. Atkins, MD

Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center

Georgetown University

Washington, D.C.

Glenn Merlino, PhD

Senior Investigator
Laboratory of Cancer Biology and Genetics
Scientific Director for Basic Research
Center for Cancer Research
National Cancer Institute, NIH
Bethesda, Maryland

Members:

Andrew Aplin, PhD

Kalbach-Newton Professor in Cancer Research

Associate Director for Basic Research

Professor, Department of Cancer Biology

Program Leader for Cancer Cell Biology and Signaling, Kimmel Cancer Center

Thomas Jefferson University

Philadelphia, Pennsylvania

Menashe Bar-Eli, PhD (Grant SRO)

Professor and Deputy Chair
Director, Cancer Biology Program, Graduate School of Biomedical Science

Co-Director, Metastasis Research Center

University of Texas MD Anderson Cancer Center and UTHealth Science Center

Houston, Texas

Marcus Bosenberg, MD, PhD

Professor of Dermatology and Pathology, Yale School of Medicine

Co-Leader, Genomics, Genetics and Epigenetics Program

Co-Director, Yale SPORE in Skin Cancer

Yale Cancer Center

New Haven, Connecticut

Clara Curiel, MD

Alan and Janice Levin Endowed Chair in Cancer Research

Associate Professor of Medicine and Dermatology

Vice Chief of Dermatology

Director, Cutaneous Oncology Program

Clinical Director, Skin Cancer Institute

The University of Arizona Cancer Center

Tucson, Arizona

Adil Daud, MD

HS Clinical Professor, Department of Medicine (Hematology/Oncology)

Director, Melanoma Clinical Research

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California

Keith T. Flaherty, MD

Director, Henri and Belinda Termeer Center for Targeted Therapies

Director, Developmental Therapeutics

Massachusetts General Hospital

Boston, Massachusetts

Alan Geller, MPH, RN

Senior Lecturer on Social and Behavioral Sciences

Department of Social and Behavioral Sciences

Harvard School of Public Health

Boston, Massachusetts

Teresa Landi, MD, PhD

Senior Investigator, Division of Cancer Epidemiology and Genetics

National Cancer Institute

Bethesda, Maryland

Martin McMahon, PhD

Cumming-Presidential Professor of Cancer Biology

Senior Director for Preclinical Translation

Huntsman Cancer Institute & Dept. of Dermatology

Salt Lake City, Utah

Ze’ev A. Ronai, PhD

Professor and Scientific Director
Sanford Burnham Prebys Medical Discovery Institute
La Jolla, California

Keiran Smalley, PhD

Professor and Donald A. Adam Endowed Chair in Melanoma Research

Director, Melanoma and Skin Cancers Center of Excellence

H. Lee Moffitt Cancer Center & Research Institute

Tampa, Florida

Jeff Sosman, MD

Professor of Medicine
Director, Melanoma Program

Director, Faculty Development
Co-Leader, Translational Research in Solid Tumors
Robert H. Laurie Comprehensive Cancer Center of Northwestern University

Chicago, Illinois

Jennifer Wargo, MD, MMSc

Associate Professor, Department of Surgical Oncology, Division of Surgery

University of Texas MD Anderson Cancer Center

Houston, Texas

Ashani Weeraratna, PhD

Ira Brind Professor

Professor & Co-Program Leader, Immunology, Microenvironment & Metastasis Program

The Wistar Institute